HEADER TRANSCRIPTION/TRANSCRIPTION INHIBITOR 15-AUG-12 4GM9 TITLE CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-401 COMPND MOL_ID: 1; COMPND 2 MOLECULE: WD REPEAT-CONTAINING PROTEIN 5; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 22-334; COMPND 5 SYNONYM: WDR5, BMP2-INDUCED 3-KB GENE PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: MM-401; COMPND 9 CHAIN: E, F; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WDR5, BIG3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B-SUMO; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES KEYWDS MLL1, HISTONE METHYLTRANSFERASE, WD40, TRANSCRIPTION-TRANSCRIPTION KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.KARATAS,E.C.TOWNSEND,Y.CHEN,D.BERNARD,L.LIU,Y.DOU,M.LEI,S.WANG REVDAT 2 24-JAN-18 4GM9 1 AUTHOR JRNL REVDAT 1 19-FEB-14 4GM9 0 JRNL AUTH H.KARATAS,E.C.TOWNSEND,Y.CHEN,D.BERNARD,L.LIU,Y.DOU,M.LEI, JRNL AUTH 2 S.WANG JRNL TITL CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND JRNL TITL 2 MM-401 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7_650) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.82 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 32442 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.161 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1634 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.8278 - 4.8045 0.97 2583 126 0.1670 0.1969 REMARK 3 2 4.8045 - 3.8146 0.99 2602 128 0.1312 0.1572 REMARK 3 3 3.8146 - 3.3328 0.99 2572 155 0.1431 0.1957 REMARK 3 4 3.3328 - 3.0282 0.99 2613 139 0.1517 0.2025 REMARK 3 5 3.0282 - 2.8112 0.99 2615 132 0.1666 0.2162 REMARK 3 6 2.8112 - 2.6455 0.98 2579 127 0.1666 0.2164 REMARK 3 7 2.6455 - 2.5131 0.98 2563 140 0.1694 0.2121 REMARK 3 8 2.5131 - 2.4037 0.98 2568 161 0.1651 0.2418 REMARK 3 9 2.4037 - 2.3112 0.98 2583 121 0.1671 0.2113 REMARK 3 10 2.3112 - 2.2314 0.97 2524 141 0.1780 0.2503 REMARK 3 11 2.2314 - 2.1617 0.97 2592 138 0.1774 0.2477 REMARK 3 12 2.1617 - 2.1000 0.92 2414 126 0.1878 0.2524 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 43.21 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.52540 REMARK 3 B22 (A**2) : 5.18160 REMARK 3 B33 (A**2) : -4.65620 REMARK 3 B12 (A**2) : 2.31170 REMARK 3 B13 (A**2) : 1.00770 REMARK 3 B23 (A**2) : -0.18920 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 5002 REMARK 3 ANGLE : 0.919 6789 REMARK 3 CHIRALITY : 0.065 766 REMARK 3 PLANARITY : 0.003 840 REMARK 3 DIHEDRAL : 14.424 1789 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GM9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000074360. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : DIAMOND(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32452 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.16700 REMARK 200 FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2H14 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG4000, 0.2 M MAGNESIUM CHLORIDE, REMARK 280 0.1 M TRIS-HCL, PH 8.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293.00K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE MM-401 IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: MM-401 REMARK 400 CHAIN: E REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 22 REMARK 465 ALA A 23 REMARK 465 ASP A 211 REMARK 465 ASP A 212 REMARK 465 SER B 22 REMARK 465 ALA B 23 REMARK 465 THR B 24 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 542 O HOH A 552 1.82 REMARK 500 O HOH A 523 O HOH A 544 1.84 REMARK 500 O HOH A 519 O HOH A 550 1.97 REMARK 500 O HOH A 551 O HOH A 640 2.04 REMARK 500 O HOH B 582 O HOH B 623 2.05 REMARK 500 O HOH A 566 O HOH A 576 2.06 REMARK 500 O HOH B 406 O HOH B 495 2.10 REMARK 500 O HOH A 493 O HOH A 527 2.12 REMARK 500 O HOH A 479 O HOH A 524 2.12 REMARK 500 O HOH A 555 O HOH A 604 2.19 REMARK 500 O HOH B 479 O HOH B 626 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 151 7.45 81.67 REMARK 500 PHE A 219 139.61 -170.53 REMARK 500 LEU A 234 41.89 -78.42 REMARK 500 LYS A 245 -11.64 -141.61 REMARK 500 ASN A 257 89.70 -155.86 REMARK 500 LYS A 259 -44.30 -135.76 REMARK 500 LEU A 321 -157.90 -80.66 REMARK 500 ASP A 324 -68.45 -134.09 REMARK 500 GLU B 151 2.82 82.06 REMARK 500 ASN B 214 73.39 -150.91 REMARK 500 LEU B 234 38.51 -75.67 REMARK 500 ASN B 257 86.00 -157.64 REMARK 500 LEU B 321 -159.31 -84.06 REMARK 500 ASP B 324 -66.23 -136.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF MM-401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF MM-401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4GM3 RELATED DB: PDB REMARK 900 RELATED ID: 4GM8 RELATED DB: PDB REMARK 900 RELATED ID: 4GMB RELATED DB: PDB DBREF 4GM9 A 22 334 UNP P61964 WDR5_HUMAN 22 334 DBREF 4GM9 B 22 334 UNP P61964 WDR5_HUMAN 22 334 DBREF 4GM9 E 1 5 PDB 4GM9 4GM9 1 5 DBREF 4GM9 F 1 5 PDB 4GM9 4GM9 1 5 SEQRES 1 A 313 SER ALA THR GLN SER LYS PRO THR PRO VAL LYS PRO ASN SEQRES 2 A 313 TYR ALA LEU LYS PHE THR LEU ALA GLY HIS THR LYS ALA SEQRES 3 A 313 VAL SER SER VAL LYS PHE SER PRO ASN GLY GLU TRP LEU SEQRES 4 A 313 ALA SER SER SER ALA ASP LYS LEU ILE LYS ILE TRP GLY SEQRES 5 A 313 ALA TYR ASP GLY LYS PHE GLU LYS THR ILE SER GLY HIS SEQRES 6 A 313 LYS LEU GLY ILE SER ASP VAL ALA TRP SER SER ASP SER SEQRES 7 A 313 ASN LEU LEU VAL SER ALA SER ASP ASP LYS THR LEU LYS SEQRES 8 A 313 ILE TRP ASP VAL SER SER GLY LYS CYS LEU LYS THR LEU SEQRES 9 A 313 LYS GLY HIS SER ASN TYR VAL PHE CYS CYS ASN PHE ASN SEQRES 10 A 313 PRO GLN SER ASN LEU ILE VAL SER GLY SER PHE ASP GLU SEQRES 11 A 313 SER VAL ARG ILE TRP ASP VAL LYS THR GLY LYS CYS LEU SEQRES 12 A 313 LYS THR LEU PRO ALA HIS SER ASP PRO VAL SER ALA VAL SEQRES 13 A 313 HIS PHE ASN ARG ASP GLY SER LEU ILE VAL SER SER SER SEQRES 14 A 313 TYR ASP GLY LEU CYS ARG ILE TRP ASP THR ALA SER GLY SEQRES 15 A 313 GLN CYS LEU LYS THR LEU ILE ASP ASP ASP ASN PRO PRO SEQRES 16 A 313 VAL SER PHE VAL LYS PHE SER PRO ASN GLY LYS TYR ILE SEQRES 17 A 313 LEU ALA ALA THR LEU ASP ASN THR LEU LYS LEU TRP ASP SEQRES 18 A 313 TYR SER LYS GLY LYS CYS LEU LYS THR TYR THR GLY HIS SEQRES 19 A 313 LYS ASN GLU LYS TYR CYS ILE PHE ALA ASN PHE SER VAL SEQRES 20 A 313 THR GLY GLY LYS TRP ILE VAL SER GLY SER GLU ASP ASN SEQRES 21 A 313 LEU VAL TYR ILE TRP ASN LEU GLN THR LYS GLU ILE VAL SEQRES 22 A 313 GLN LYS LEU GLN GLY HIS THR ASP VAL VAL ILE SER THR SEQRES 23 A 313 ALA CYS HIS PRO THR GLU ASN ILE ILE ALA SER ALA ALA SEQRES 24 A 313 LEU GLU ASN ASP LYS THR ILE LYS LEU TRP LYS SER ASP SEQRES 25 A 313 CYS SEQRES 1 B 313 SER ALA THR GLN SER LYS PRO THR PRO VAL LYS PRO ASN SEQRES 2 B 313 TYR ALA LEU LYS PHE THR LEU ALA GLY HIS THR LYS ALA SEQRES 3 B 313 VAL SER SER VAL LYS PHE SER PRO ASN GLY GLU TRP LEU SEQRES 4 B 313 ALA SER SER SER ALA ASP LYS LEU ILE LYS ILE TRP GLY SEQRES 5 B 313 ALA TYR ASP GLY LYS PHE GLU LYS THR ILE SER GLY HIS SEQRES 6 B 313 LYS LEU GLY ILE SER ASP VAL ALA TRP SER SER ASP SER SEQRES 7 B 313 ASN LEU LEU VAL SER ALA SER ASP ASP LYS THR LEU LYS SEQRES 8 B 313 ILE TRP ASP VAL SER SER GLY LYS CYS LEU LYS THR LEU SEQRES 9 B 313 LYS GLY HIS SER ASN TYR VAL PHE CYS CYS ASN PHE ASN SEQRES 10 B 313 PRO GLN SER ASN LEU ILE VAL SER GLY SER PHE ASP GLU SEQRES 11 B 313 SER VAL ARG ILE TRP ASP VAL LYS THR GLY LYS CYS LEU SEQRES 12 B 313 LYS THR LEU PRO ALA HIS SER ASP PRO VAL SER ALA VAL SEQRES 13 B 313 HIS PHE ASN ARG ASP GLY SER LEU ILE VAL SER SER SER SEQRES 14 B 313 TYR ASP GLY LEU CYS ARG ILE TRP ASP THR ALA SER GLY SEQRES 15 B 313 GLN CYS LEU LYS THR LEU ILE ASP ASP ASP ASN PRO PRO SEQRES 16 B 313 VAL SER PHE VAL LYS PHE SER PRO ASN GLY LYS TYR ILE SEQRES 17 B 313 LEU ALA ALA THR LEU ASP ASN THR LEU LYS LEU TRP ASP SEQRES 18 B 313 TYR SER LYS GLY LYS CYS LEU LYS THR TYR THR GLY HIS SEQRES 19 B 313 LYS ASN GLU LYS TYR CYS ILE PHE ALA ASN PHE SER VAL SEQRES 20 B 313 THR GLY GLY LYS TRP ILE VAL SER GLY SER GLU ASP ASN SEQRES 21 B 313 LEU VAL TYR ILE TRP ASN LEU GLN THR LYS GLU ILE VAL SEQRES 22 B 313 GLN LYS LEU GLN GLY HIS THR ASP VAL VAL ILE SER THR SEQRES 23 B 313 ALA CYS HIS PRO THR GLU ASN ILE ILE ALA SER ALA ALA SEQRES 24 B 313 LEU GLU ASN ASP LYS THR ILE LYS LEU TRP LYS SER ASP SEQRES 25 B 313 CYS SEQRES 1 E 5 ALQ 0XO ARG ABA PG9 SEQRES 1 F 5 ALQ 0XO ARG ABA PG9 MODRES 4GM9 ABA E 4 ALA ALPHA-AMINOBUTYRIC ACID MODRES 4GM9 ABA F 4 ALA ALPHA-AMINOBUTYRIC ACID HET ALQ E 1 5 HET 0XO E 2 10 HET ABA E 4 6 HET PG9 E 5 10 HET ALQ F 1 5 HET 0XO F 2 10 HET ABA F 4 6 HET PG9 F 5 10 HETNAM ALQ 2-METHYL-PROPIONIC ACID HETNAM 0XO 2-METHYL-D-LYSINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM PG9 D-PHENYLGLYCINE FORMUL 3 ALQ 2(C4 H8 O2) FORMUL 3 0XO 2(C7 H16 N2 O2) FORMUL 3 ABA 2(C4 H9 N O2) FORMUL 3 PG9 2(C8 H9 N O2) FORMUL 5 HOH *523(H2 O) SHEET 1 A 4 ALA A 36 LEU A 41 0 SHEET 2 A 4 ILE A 327 LYS A 331 -1 O ILE A 327 N LEU A 41 SHEET 3 A 4 ILE A 315 ALA A 320 -1 N ILE A 316 O TRP A 330 SHEET 4 A 4 VAL A 304 CYS A 309 -1 N ALA A 308 O ALA A 317 SHEET 1 B 4 VAL A 48 PHE A 53 0 SHEET 2 B 4 TRP A 59 SER A 64 -1 O SER A 63 N SER A 49 SHEET 3 B 4 ILE A 69 GLY A 73 -1 O TRP A 72 N LEU A 60 SHEET 4 B 4 PHE A 79 ILE A 83 -1 O ILE A 83 N ILE A 69 SHEET 1 C 4 ILE A 90 TRP A 95 0 SHEET 2 C 4 LEU A 101 SER A 106 -1 O VAL A 103 N ALA A 94 SHEET 3 C 4 THR A 110 ASP A 115 -1 O TRP A 114 N LEU A 102 SHEET 4 C 4 LYS A 120 LYS A 126 -1 O LEU A 122 N ILE A 113 SHEET 1 D 4 VAL A 132 PHE A 137 0 SHEET 2 D 4 LEU A 143 SER A 148 -1 O VAL A 145 N ASN A 136 SHEET 3 D 4 VAL A 153 ASP A 157 -1 O TRP A 156 N ILE A 144 SHEET 4 D 4 CYS A 163 LEU A 167 -1 O LEU A 167 N VAL A 153 SHEET 1 E 4 VAL A 174 PHE A 179 0 SHEET 2 E 4 LEU A 185 SER A 190 -1 O VAL A 187 N HIS A 178 SHEET 3 E 4 CYS A 195 ASP A 199 -1 O TRP A 198 N ILE A 186 SHEET 4 E 4 CYS A 205 LEU A 209 -1 O LEU A 206 N ILE A 197 SHEET 1 F 4 VAL A 217 PHE A 222 0 SHEET 2 F 4 TYR A 228 THR A 233 -1 O ALA A 232 N PHE A 219 SHEET 3 F 4 THR A 237 ASP A 242 -1 O TRP A 241 N ILE A 229 SHEET 4 F 4 LYS A 247 TYR A 252 -1 O TYR A 252 N LEU A 238 SHEET 1 G 4 ALA A 264 SER A 267 0 SHEET 2 G 4 TRP A 273 SER A 276 -1 O VAL A 275 N ASN A 265 SHEET 3 G 4 VAL A 283 ASN A 287 -1 O TYR A 284 N SER A 276 SHEET 4 G 4 ILE A 293 LEU A 297 -1 O VAL A 294 N ILE A 285 SHEET 1 H 4 ALA B 36 LEU B 41 0 SHEET 2 H 4 ILE B 327 LYS B 331 -1 O ILE B 327 N LEU B 41 SHEET 3 H 4 ILE B 315 ALA B 320 -1 N ILE B 316 O TRP B 330 SHEET 4 H 4 VAL B 304 CYS B 309 -1 N ALA B 308 O ALA B 317 SHEET 1 I 4 VAL B 48 PHE B 53 0 SHEET 2 I 4 TRP B 59 SER B 64 -1 O ALA B 61 N LYS B 52 SHEET 3 I 4 ILE B 69 GLY B 73 -1 O TRP B 72 N LEU B 60 SHEET 4 I 4 PHE B 79 ILE B 83 -1 O ILE B 83 N ILE B 69 SHEET 1 J 4 ILE B 90 TRP B 95 0 SHEET 2 J 4 LEU B 101 SER B 106 -1 O VAL B 103 N ALA B 94 SHEET 3 J 4 LEU B 111 ASP B 115 -1 O TRP B 114 N LEU B 102 SHEET 4 J 4 CYS B 121 LEU B 125 -1 O LEU B 125 N LEU B 111 SHEET 1 K 4 VAL B 132 PHE B 137 0 SHEET 2 K 4 LEU B 143 SER B 148 -1 O VAL B 145 N ASN B 136 SHEET 3 K 4 VAL B 153 ASP B 157 -1 O TRP B 156 N ILE B 144 SHEET 4 K 4 CYS B 163 LEU B 167 -1 O LEU B 167 N VAL B 153 SHEET 1 L 4 VAL B 174 PHE B 179 0 SHEET 2 L 4 LEU B 185 SER B 190 -1 O VAL B 187 N HIS B 178 SHEET 3 L 4 CYS B 195 ASP B 199 -1 O TRP B 198 N ILE B 186 SHEET 4 L 4 CYS B 205 LEU B 209 -1 O LEU B 206 N ILE B 197 SHEET 1 M 4 VAL B 217 PHE B 222 0 SHEET 2 M 4 ILE B 229 THR B 233 -1 O ALA B 232 N PHE B 219 SHEET 3 M 4 THR B 237 ASP B 242 -1 O LYS B 239 N ALA B 231 SHEET 4 M 4 LYS B 247 TYR B 252 -1 O LYS B 247 N ASP B 242 SHEET 1 N 4 ALA B 264 SER B 267 0 SHEET 2 N 4 TRP B 273 SER B 276 -1 O VAL B 275 N ASN B 265 SHEET 3 N 4 VAL B 283 ASN B 287 -1 O TYR B 284 N SER B 276 SHEET 4 N 4 ILE B 293 LEU B 297 -1 O VAL B 294 N ILE B 285 LINK C ALQ E 1 NAC 0XO E 2 1555 1555 1.34 LINK CAE 0XO E 2 N ARG E 3 1555 1555 1.33 LINK C ARG E 3 N ABA E 4 1555 1555 1.33 LINK C ABA E 4 N PG9 E 5 1555 1555 1.34 LINK C ALQ F 1 NAC 0XO F 2 1555 1555 1.34 LINK CAE 0XO F 2 N ARG F 3 1555 1555 1.33 LINK C ARG F 3 N ABA F 4 1555 1555 1.33 LINK C ABA F 4 N PG9 F 5 1555 1555 1.33 LINK N02 0XO E 2 C PG9 E 5 1555 1555 1.33 LINK N02 0XO F 2 C PG9 F 5 1555 1555 1.33 SITE 1 AC1 15 SER A 49 GLY A 89 ILE A 90 SER A 91 SITE 2 AC1 15 ASP A 107 PHE A 133 LYS A 259 TYR A 260 SITE 3 AC1 15 CYS A 261 PHE A 263 HOH A 512 HOH E 101 SITE 4 AC1 15 HOH E 102 HOH E 104 HOH E 105 SITE 1 AC2 16 SER B 49 GLY B 89 ILE B 90 SER B 91 SITE 2 AC2 16 ASP B 107 PHE B 133 TYR B 260 CYS B 261 SITE 3 AC2 16 PHE B 263 HOH B 424 HOH B 484 HOH F 101 SITE 4 AC2 16 HOH F 102 HOH F 103 HOH F 104 HOH F 106 CRYST1 46.904 47.242 68.896 88.50 89.50 74.53 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021320 -0.005902 -0.000039 0.00000 SCALE2 0.000000 0.021964 -0.000544 0.00000 SCALE3 0.000000 0.000000 0.014520 0.00000 MASTER 283 0 8 0 56 0 8 6 0 0 0 52 END